Biofrontera AG
BFFTF · OTC
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $1,905 | $1,680 | $1,196 | $706 |
| - Cash | $2,873 | $4,379 | $3,817 | $1,343 |
| + Debt | $994 | $2,141 | $7,236 | $6,090 |
| Enterprise Value | $26 | -$558 | $4,615 | $5,453 |
| Revenue | $9,012 | $7,839 | $7,901 | $10,596 |
| % Growth | 15% | -0.8% | -25.4% | – |
| Gross Profit | $4,211 | $3,497 | $3,955 | $4,933 |
| % Margin | 46.7% | 44.6% | 50.1% | 46.6% |
| EBITDA | -$4,960 | $692 | -$8,708 | $4,048 |
| % Margin | -55% | 8.8% | -110.2% | 38.2% |
| Net Income | -$5,669 | -$257 | -$10,437 | $3,526 |
| % Margin | -62.9% | -3.3% | -132.1% | 33.3% |
| EPS Diluted | -0.98 | -0.051 | -2.88 | 1.65 |
| % Growth | -1,840.6% | 98.2% | -274.5% | – |
| Operating Cash Flow | -$1,208 | -$4,720 | -$3,325 | -$8,866 |
| Capital Expenditures | $50 | -$2 | -$57 | $9 |
| Free Cash Flow | -$1,158 | -$4,722 | -$3,382 | -$8,857 |